The approval covers one specific thin steak
Aleph Farms announced in January 2024 that, following a safety review, Israel's Ministry of Health had issued a so-called no-questions letter for Aleph Cuts. It was the first regulatory approval for cultivated beef and the first such approval in the Middle East. The decision applied to the product, process and conditions described in the submission. The company still had to complete a good manufacturing practice inspection and comply with labelling and marketing requirements.
An Aleph Cut is not a whole piece of meat grown without any other ingredients. It consists of cultivated bovine cells combined with a plant-based matrix made from soy and wheat. The starter cells come from a fertilised cow egg, and according to the company the production process uses neither foetal bovine serum nor antibiotics. An exact description matters for allergens, nutrition and consumer expectations. The word cultivated describes how the cellular component is produced; it does not mean that the product contains no plant ingredients.
Cells need a medium, a scaffold and a controlled environment
Production begins with a cell line that multiplies in a nutrient-rich culture medium. The cells then differentiate and form muscle and other structures on a scaffold. At larger volumes, the process must maintain sterility, temperature, oxygen and the composition of the medium. Unlike microbial fermentation, animal cells are more sensitive and grow more slowly. Moving from a laboratory vessel to an industrial bioreactor is therefore the central technical and economic challenge.
The company emphasises that it uses non-modified and non-immortalised cells. That may be reassuring to consumers and regulators, but it also places demands on production stability. Every batch needs checks of identity, microbiology, residual medium and nutritional composition. Regulatory approval confirms that the Israeli authority assessed the submitted process; it does not mean that the safety finding automatically applies to every future change in the recipe or factory. A significant change may require further consultation.
Price and capacity will determine whether a real market emerges
Cultivated meat is usually launched first in limited quantities and at selected restaurants. Production costs remain significantly higher than for conventional beef and are sensitive to the cost of the medium, bioreactor capital, yield and energy. Aleph Farms must gradually increase volume without losing quality. Regulatory first-mover status benefits the brand and its partners, but it does not solve the economics by itself. The product will become a broader category only when it can be made repeatedly and sold at an acceptable price.
The company has published techno-economic analyses and is building partnerships in several countries. Those models contain assumptions about future capacity and input prices. Investors and food manufacturers need to distinguish today's verified production from a planned factory. The decisive figures will be actual kilograms, yield, number of batches and contracts with manufacturing partners. Consistency of taste and texture also matters in food: consumers will not keep buying a technology if the product does not succeed as food.
The environmental result depends on energy
Cultivated beef may require less land and fewer animals and avoid some of the methane emissions associated with livestock. Bioreactors, nutrient production and sterile operations, however, consume energy. The carbon benefit therefore depends on the electricity source, process efficiency and the livestock system used for comparison. Results from early life-cycle assessments differ according to their assumptions. A responsible manufacturer should update the calculation with data from the actual factory and should not promise one universal percentage for future capacity.
Food safety may be another argument because a controlled environment limits some pathogens and does not require slaughter. At the same time, it creates new critical points in the medium, cell bank and sterile process. Regulators therefore assess toxicology, allergens, microbiology and chemical safety. Cultivation is not automatically safer simply because it looks clean. It is a different production system that needs its own control plan and transparent traceability.
Kosher status raises a distinct consumer question
Aleph Farms obtained an opinion from Israel's chief rabbi stating that, under the described conditions, the product may be considered pareve. The religious assessment depends on the origin of the cells, the process and the particular authorities, and may not be uniform everywhere. It is significant for the Israeli market because it affects how foods may be combined and how restaurants operate. Customers should see a specific certification, not a general claim that all cultivated meat has the same status.
Acceptance will also be shaped by the product's name and labelling. Consumers need to know that it is a cell-cultivated, partly plant-based food, what allergens it contains and what its nutritional values are. An exaggerated effort to present it as completely identical to beef may weaken trust. The new category is more likely to gain acceptance through accurate information and tasting than through an argument about whether it is “natural”. National labelling rules will form part of the commercial strategy in every market.
Being first is the beginning of commercialisation
After the Israeli decision, Aleph Farms continued with applications and partnerships in other countries. Each market has its own safety and manufacturing assessment. Czech food companies may find opportunities in ingredients, bioprocessing, equipment and quality control even though the finished steak is not yet sold in the EU. Any cooperation must respect the European novel food process and should not pre-empt its outcome through marketing imports.
The Aleph Cuts story shows the difference between a research prototype and a regulated product. The company had to describe the cells, medium, production process and final food and accept conditions for oversight. That is a genuine commercial milestone. The next stage is even more demanding: producing at greater volume, controlling price and persuading diners through taste. Factory data and repeat purchases, not the world-first label alone, will decide the future of cultivated beef.
Sources and editorial note
This article was prepared by the Jews.cz editorial team from the public materials listed below. Statements made by a company or institution are explicitly distinguished from independently documented facts and from editorial interpretation.
